Enduring Clinical Remission in Refractory Celiac Disease Type II With Tofacitinib: An Open-Label Clinical Study

被引：5
|
作者：
Dieckman, Tessa [1 ,2 ]
Schumann, Michael [3 ]
Beaumont, Hanneke [2 ]
Bontkes, Hetty j. [4 ]
Koning, Frits [1 ]
Bouma, Gerd [2 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Immunol, Leiden, Netherlands
[2] Vrije Univ Amsterdam Amsterdam Gastroenterol Endoc, Dept Gastroenterol & Hepatol, Amsterdam UMC, Amsterdam, Netherlands
[3] Charite Univ Med Berlin, Div Gastroenterol Infect Dis & Rheumatol, Campus Benjamin Franklin, Berlin, Germany
[4] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam UMC locat, Lab Specialized Diagnost & Res,Dept Lab Med,Med Im, Amsterdam, Netherlands
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 22卷 / 11期
关键词：
BUDESONIDE;
D O I：
10.1016/j.cgh.2024.05.022
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2334 / 2336
页数：3
相关论文
共 50 条
  • [1] Comments on "Enduring Clinical Remission in Refractory Celiac Disease Type II with Tofacitinib: An Open-Label Clinical Study"
    Goyal, Manjeet kumar
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2025, 23 (04) : 678 - 679
  • [2] Enduring Clinical Remission in Refractory Celiac Disease Type II with Tofacitinib: An Open-Label Clinical Study- The Reply
    Dieckman, Tessa
    Schumann, Michael
    Beaumont, Hanneke
    Bontkes, Hetty j.
    Koning, Frits
    Bouma, Gerd
    RCDII Tofacitinib Consortium
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2025, 22 (04) : 679 - 680
  • [3] Open-label pilot study of tofacitinib 2% for the treatment of refractory vitiligo
    Mobasher, P.
    Guerra, R.
    Li, S. J.
    Frangos, J.
    Ganesan, A. K.
    Huang, V.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (04) : 1047 - 1049
  • [4] Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients
    Paik, Julie J.
    Casciola-Rosen, Livia
    Shin, Joseph Yusup
    Albayda, Jemima
    Tiniakou, Eleni
    Leung, Doris G.
    Gutierrez-Alamillo, Laura
    Perin, Jamie
    Florea, Liliana
    Antonescu, Corina
    Leung, Sherry G.
    Purwin, Grazyna
    Koenig, Andrew
    Christopher-Stine, Lisa
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 875 - 884
  • [5] Persistence of Tofacitinib Treatment in Patients With Ulcerative Colitis Who Entered the Open-Label, Long-Term Extension Study, OCTAVE OPEN in Remission or With a Clinical Response
    Panaccione, Remo
    Abreu, Maria T.
    Lazariciu, Irina
    Mundayat, Rajiv
    Lawendy, Nervin
    Salese, Leonardo
    Woolcott, John C.
    Sands, Bruce E.
    Chaparro, Maria
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S351 - S351
  • [6] A phase I/II open-label gene replacement clinical study for late onset Pompe disease
    Mozaffar, Tahseen
    Day, John
    Foo, Cheryl Wong Po
    Bachtell, Nathan
    Conner, Edward
    NEUROLOGY, 2021, 96 (15)
  • [7] A phase I/II open-label gene replacement clinical study for late onset Pompe disease
    Day, John W.
    Mozaffar, Tahseen
    Foo, Cheryl Wong Po
    Bachtell, Nathan
    Conner, Edward
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S32 - S32
  • [8] Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study
    He, Yao
    Mao, Ren
    Chen, Fang
    Xu, Ping-Ping
    Chen, Bai-Li
    Wu, Yun
    Qiu, Yun
    Zhang, Sheng-Hong
    Feng, Rui
    Zeng, Zhi-Rong
    Ben-Horin, Shomron
    Chen, Min-Hu
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (05) : 397 - 406
  • [9] Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study
    Mao, R.
    He, Y.
    Ben-Horin, S.
    Chen, M. -H.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S300 - S301
  • [10] Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study
    Kubo, Satoshi
    Miyazaki, Yusuke
    Amano, Koichi
    Matsui, Kiyoshi
    Kameda, Hideto
    Inoue, Yoshino
    Nakayamada, Shingo
    Ogura, Takehisa
    Kaneko, Yuko
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    RMD OPEN, 2023, 9 (02):
12345